Agilon Health Appoints Jeff Schwaneke As New CFO, Effective July 1, 2024

6/5/24 8:01:36 AM ET

Misc Health and Biotechnology Services

Health Care

Get the next $AGL alert in real time by email

agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Jeff Schwaneke, an experienced finance, operational and managed care executive and director on agilon's board, will join the Company as chief financial officer and executive vice president effective July 1, 2024. He will be a member of agilon's Executive Leadership team reporting to chief executive officer (CEO), Steve Sell. Schwaneke succeeds Timothy Bensley, who announced his retirement from agilon in early 2024. Bensley has agreed to stay on through a transition period.

Get the next $AGL alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AGL

Date	Price Target	Rating	Analyst
11/11/2024		Mkt Outperform → Mkt Perform	JMP Securities
11/8/2024		Outperform → Mkt Perform	William Blair
10/30/2024	$7.00 → $2.50	Neutral → Sell	Citigroup
10/2/2024	$3.00	Buy → Underperform	BofA Securities
5/30/2024	$6.00	Neutral	Robert W. Baird
4/22/2024	$6.00	Neutral	Citigroup
3/6/2024	$5.00	Underweight	Barclays
2/26/2024	$25.00 → $6.50	Buy → Hold	Jefferies

More analyst ratings

$AGL
Press Releases

Fastest customizable press release news feed in the world

agilon health Reports Third Quarter 2024 Results
Revenue increased 28% to $1.45 billion, Medicare Advantage membership increased 37% to 525,000, and total members on the agilon platform grew 39% to 657,000 Third quarter results were affected by lower-than-expected 2024 risk adjustment, negative prior year development mainly from risk adjustment and Part D, and higher current year medical expenses Adjusted full year guidance reflects Q3 results and updated Q4 cost trends agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2024. "Our full-risk model enables primary care physicians to deliver high-quality c
11/7/24 4:00:00 PM ET
$AGL
Misc Health and Biotechnology Services
Health Care
agilon health Sets Date to Report Third Quarter 2024 Financial Results
agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2024 after the market closes on Thursday, November 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 520026. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of
10/17/24 4:00:00 PM ET
$AGL
Misc Health and Biotechnology Services
Health Care
agilon health Reports Second Quarter 2024 Results
Revenue increased 39% to $1.5 billion, Medicare Advantage membership increased 38% to 513,000, and total members on the agilon platform grew 40% to 645,000 Executing targeted action plan and prioritizing profitability First half results reflect retroactive membership adjustments to January 1, 2024 related to agilon's termination of select contracts Maintains 2024 Medical Margin and Adjusted EBITDA Guidance agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the second quarter ended June 30, 2024. "Our second quarter results were in-line with our guidance, and we are maintaining medical margin
8/6/24 4:00:00 PM ET
$AGL
Misc Health and Biotechnology Services
Health Care

$AGL
Market Insights

Live Market Insights

Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 50 points on Thursday. Shares of Leslie’s, Inc. (NASDAQ:LESL) fell sharply in today's pre-market trading after the company issued preliminary third-quarter financial results below estimates and cut its FY24 guidance. After the market close on Wednesday, Leslie's announced it now expects third-quarter revenue of approximately $570 million versus estimates of $615.407 million. The pool supply company anticipates third-quarter adjusted earnings of 32 cents to 33 cents per share versus Benzinga Pro estimates of 42 cents per share. Leslie's also cut its full-year 2024 revenue guidance from a range of $1.14
7/18/24 8:22:49 AM ET
$ADMA
$AGL
$BYND
$DPZ
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Misc Health and Biotechnology Services
Packaged Foods
Beyond The Numbers: 6 Analysts Discuss Agilon Health Stock
Analysts' ratings for Agilon Health (NYSE:AGL) over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 0 6 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 2 0 0 3M Ago 0 0 3 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $6.48, with a high estimate of $7.00 and a low estimate of $6.00. Highlighting a 5.4% decrease, the current average has fallen from the pr
7/9/24 11:00:57 AM ET
$AGL
Misc Health and Biotechnology Services
Health Care
Evercore ISI Group Maintains In-Line on Agilon Health, Raises Price Target to $7
Evercore ISI Group analyst Elizabeth Anderson maintains Agilon Health (NYSE:AGL) with a In-Line and raises the price target from $5.5 to $7.
7/9/24 10:59:15 AM ET
$AGL
Misc Health and Biotechnology Services
Health Care

agilon health Reports Third Quarter 2024 Results
Revenue increased 28% to $1.45 billion, Medicare Advantage membership increased 37% to 525,000, and total members on the agilon platform grew 39% to 657,000 Third quarter results were affected by lower-than-expected 2024 risk adjustment, negative prior year development mainly from risk adjustment and Part D, and higher current year medical expenses Adjusted full year guidance reflects Q3 results and updated Q4 cost trends agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2024. "Our full-risk model enables primary care physicians to deliver high-quality c
11/7/24 4:00:00 PM ET
$AGL
Misc Health and Biotechnology Services
Health Care
agilon health Sets Date to Report Third Quarter 2024 Financial Results
agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2024 after the market closes on Thursday, November 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (404) 975-4839 for international participants and referencing participant code 520026. A simultaneous webcast can be accessed by visiting the "Events & Presentations" section of agilon's Investor Relations website at https://investors.agilonhealth.com. A replay of
10/17/24 4:00:00 PM ET
$AGL
Misc Health and Biotechnology Services
Health Care
agilon health Reports Second Quarter 2024 Results
Revenue increased 39% to $1.5 billion, Medicare Advantage membership increased 38% to 513,000, and total members on the agilon platform grew 40% to 645,000 Executing targeted action plan and prioritizing profitability First half results reflect retroactive membership adjustments to January 1, 2024 related to agilon's termination of select contracts Maintains 2024 Medical Margin and Adjusted EBITDA Guidance agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the second quarter ended June 30, 2024. "Our second quarter results were in-line with our guidance, and we are maintaining medical margin
8/6/24 4:00:00 PM ET
$AGL
Misc Health and Biotechnology Services
Health Care

agilon health Appoints Karthik Rao, M.D., as Chief Medical Officer
Dr. Rao to Continue to Lead Clinical Strategy and Drive Physician Network Performance Alongside agilon's Chief Clinical Officer Kevin Spencer, M.D. agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that after a comprehensive search Karthik Rao, M.D., who has served as agilon's interim chief medical officer (CMO) since February 2024, has been appointed to the permanent CMO role, effective immediately. He previously served as senior medical director and vice president, network performance, at the company. Prior to joining agilon in 2022, Dr. Rao held several roles in value-based care, including nearly a d
7/10/24 8:00:00 AM ET
$AGL
Misc Health and Biotechnology Services
Health Care
agilon health Names Jeff Schwaneke New Chief Financial Officer
agilon health, inc. (NYSE:AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Jeff Schwaneke, an experienced finance, operational and managed care executive and director on agilon's board, will join the Company as chief financial officer and executive vice president effective July 1, 2024. He will be a member of agilon's Executive Leadership team reporting to chief executive officer (CEO), Steve Sell. Schwaneke succeeds Timothy Bensley, who announced his retirement from agilon in early 2024. Bensley has agreed to stay on through a transition period. Schwaneke was most recently executive vice president, Health Care Enterprises,
6/5/24 8:00:00 AM ET
$AGL
Misc Health and Biotechnology Services
Health Care
agilon health, inc. investors: Please contact the Portnoy Law Firm to recover your losses; May 28, 2024 deadline
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises agilon health, inc. (NYSE:AGL) investors that a lawsuit was filed on behalf of investors that purchased agilon securities between April 15, 2021 and February 27, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to
5/13/24 6:31:12 PM ET
$AGL
Misc Health and Biotechnology Services
Health Care

Agilon Health Appoints Jeff Schwaneke As New CFO, Effective July 1, 2024

Chat with this insight

Recent Analyst Ratings for $AGL

$AGL Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

CEO & President Sell Steven bought $67,188 worth of shares (20,000 units at $3.36) (SEC Form 4)

Kornitzer Benjamin bought 5,434 shares and covered exercise/tax liability with 1,883 shares, increasing direct ownership by 6% to 62,058 units (SEC Form 4)

Venkatachaliah Girish covered exercise/tax liability with 1,883 shares and bought 5,434 shares, increasing direct ownership by 10% to 39,950 units (SEC Form 4)

$AGL Press Releases

Fastest customizable press release news feed in the world

agilon health Reports Third Quarter 2024 Results

agilon health Sets Date to Report Third Quarter 2024 Financial Results

agilon health Reports Second Quarter 2024 Results

$AGL Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Agilon Health downgraded by JMP Securities

Agilon Health downgraded by William Blair

Agilon Health downgraded by Citigroup with a new price target

$AGL SEC Filings

agilon health inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 10-Q filed by agilon health inc.

agilon health inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

$AGL Market Insights

Live Market Insights

Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Beyond The Numbers: 6 Analysts Discuss Agilon Health Stock

Evercore ISI Group Maintains In-Line on Agilon Health, Raises Price Target to $7

$AGL Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$AGL Financials

Live finance-specific insights

$AGL Leadership Updates

Live Leadership Updates

$AGL Large Ownership Changes

This live feed shows all institutional transactions in real time.

CEO & President Sell Steven bought $67,188 worth of shares (20,000 units at $3.36) (SEC Form 4)

Chief Accounting Officer Gertsch Timothy covered exercise/tax liability with 405 shares, decreasing direct ownership by 0.69% to 57,947 units (SEC Form 4)

Chief Financial Officer Schwaneke Jeffrey A. was granted 659,880 shares, increasing direct ownership by 1,030% to 723,930 units (SEC Form 4)

agilon health Reports Third Quarter 2024 Results

agilon health Sets Date to Report Third Quarter 2024 Financial Results

agilon health Reports Second Quarter 2024 Results

agilon health Appoints Karthik Rao, M.D., as Chief Medical Officer

agilon health Names Jeff Schwaneke New Chief Financial Officer

agilon health, inc. investors: Please contact the Portnoy Law Firm to recover your losses; May 28, 2024 deadline

Amendment: SEC Form SC 13G/A filed by agilon health inc.

Amendment: SEC Form SC 13G/A filed by agilon health inc.

Amendment: SEC Form SC 13G/A filed by agilon health inc.

Recent Analyst Ratings for
$AGL

$AGL
Insider Purchases

$AGL
Press Releases

$AGL
Analyst Ratings

$AGL
SEC Filings

$AGL
Market Insights

$AGL
Insider Trading

$AGL
Financials

$AGL
Leadership Updates

$AGL
Large Ownership Changes